[HTML][HTML] Antiprotozoal drugs: challenges and opportunities
CT Supuran - Expert Opinion on Therapeutic Patents, 2023 - Taylor & Francis
Full article: Antiprotozoal drugs: challenges and opportunities Skip to Main Content Taylor
and Francis Online homepage Taylor and Francis Online homepage Log in | Register Cart 1.Home …
and Francis Online homepage Taylor and Francis Online homepage Log in | Register Cart 1.Home …
Selenium-Containing (Hetero)Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against L. amazonensis
MH Fermiano, AR das Neves, F Da Silva, MSA Barros… - Biomedicines, 2024 - mdpi.com
Leishmaniasis remains a significant global health concern, with current treatments relying
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and …
[HTML][HTML] Isopentyl caffeate as a promising drug for the treatment of leishmaniasis: An in silico and in vivo study
WS Mota, SSC Oliveira, MM Pereira, DP Souza… - Current Research in …, 2024 - Elsevier
Leishmaniasis is recognised as the second largest parasitic disease worldwide and yet a
neglected disease. The current pharmacological treatments are associated with significant …
neglected disease. The current pharmacological treatments are associated with significant …
[HTML][HTML] Design, synthesis and identification of novel molecular hybrids based on naphthoquinone aromatic hydrazides as potential trypanocide and leishmanicidal …
RD Cezar, AODA Silva, RS Lopes… - Anais da Academia …, 2024 - SciELO Brasil
In pursuit of potential agents to treat Chagas disease and leishmaniasis, we report the
design, synthesis, and identification novel naphthoquinone hydrazide-based molecular …
design, synthesis, and identification novel naphthoquinone hydrazide-based molecular …
[PDF][PDF] Current Research in Biotechnology
WS Mota, SSC Oliveira, MM Pereira… - Current Research in …, 2024 - researchgate.net
Leishmaniasis is recognised as the second largest parasitic disease worldwide and yet a
neglected disease. The current pharmacological treatments are associated with significant …
neglected disease. The current pharmacological treatments are associated with significant …
[PDF][PDF] Molecular docking and simulation studies of medicinal plant phytochemicals with Leishmania donovani adenosylmethionine decarboxylase
Visceral leishmaniasis is a neglected endemic disease caused by the intramacrophage
obligate parasite, Leishmania donovani that affects millions of people worldwide. Visceral …
obligate parasite, Leishmania donovani that affects millions of people worldwide. Visceral …